FDA Approved: DOXAZOSIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for doxazosin mesylate from Aurobindo Pharma Limited, resulting in a labeling update for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Hypertension

Drugs mentioned

• Doxazosin (doxazosin)

Snippet

SUPPL AP for DOXAZOSIN (DOXAZOSIN MESYLATE)